Urologix Inc (ULGX) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
14405 21ST AVE N MINNEAPOLIS, MN 55447 |
| State of Incorp. | MN |
| Fiscal Year End | June 30 |
| Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2015 MRQ | 6/30/2014 | 6/30/2013 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 718 | 2,290 | |||
| Cash and cash equivalent | 718 | 2,290 | |||
| Receivables | 1,426 | 2,053 | |||
| Inventory, net of allowances, customer advances and progress billings | 1,397 | 1,952 | |||
| Inventory | 1,397 | 1,952 | |||
| Prepaid expense and other current assets | ✕ | ✕ | 128 | ||
| Other undisclosed current assets | 139 | 79 | |||
| Total current assets: | 3,680 | 6,502 | |||
| Noncurrent Assets | |||||
| Inventory, Noncurrent | 141 | 662 | |||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 471 | 735 | |||
| Intangible asset, including goodwill, after accumulated amortization | 1,370 | 4,623 | |||
| Goodwill | 3,036 | ||||
| Intangible asset, excluding goodwill, after accumulated amortization | 1,370 | 1,587 | |||
| Other noncurrent assets | 5 | ✕ | |||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | 5 | ||
| Total noncurrent assets: | 1,987 | 6,025 | |||
| TOTAL ASSETS: | 5,667 | 12,527 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,458 | 1,475 | |||
| Taxes payable | 79 | 126 | |||
| Employee-related liabilities | 487 | 721 | |||
| Accounts payable and other accrued liabilities | ✕ | 892 | 628 | ||
| Debt | 747 | ||||
| Other liabilities | 499 | 602 | |||
| Deferred revenue and credits | 6 | 5 | |||
| Other undisclosed current liabilities | 1,582 | 555 | |||
| Total current liabilities: | 4,292 | 2,637 | |||
| Noncurrent Liabilities | |||||
| Long-term debt and lease obligation | 4,586 | 5,333 | |||
| Long-term debt, excluding current maturities | 4,586 | 5,333 | |||
| Liabilities, other than long-term debt | 36 | ||||
| Deferred tax liabilities, net | 36 | ||||
| Other undisclosed noncurrent liabilities | 3,766 | 4,101 | |||
| Total noncurrent liabilities: | 8,352 | 9,470 | |||
| Total liabilities: | 12,644 | 12,107 | |||
| Equity | |||||
| Equity, attributable to parent | (6,977) | 420 | |||
| Common stock | 209 | 208 | |||
| Additional paid in capital | 119,440 | 119,230 | |||
| Accumulated deficit | (126,626) | (119,018) | |||
| Total equity: | (6,977) | 420 | |||
| TOTAL LIABILITIES AND EQUITY: | 5,667 | 12,527 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2015 TTM | 6/30/2014 | 6/30/2013 | ||
|---|---|---|---|---|
| Revenues (Revenue, Net) | 14,235 | 16,590 | ||
| Cost of revenue | (8,142) | (8,407) | ||
| Gross profit: | 6,093 | 8,183 | ||
| Operating expenses | (13,023) | (12,105) | ||
| Operating loss: | (6,930) | (3,922) | ||
| Nonoperating income (expense) (loss, Foreign Currency Transaction, before Tax) | (1) | (7) | ||
| Interest and debt expense | 206 | |||
| Loss from continuing operations before equity method investments, income taxes: | (6,931) | (3,723) | ||
| Other undisclosed loss from continuing operations before income taxes | (693) | (555) | ||
| Loss from continuing operations before income taxes: | (7,624) | (4,278) | ||
| Income tax expense (benefit) | 16 | (14) | ||
| Loss from continuing operations: | (7,608) | (4,292) | ||
| Loss before gain (loss) on sale of properties: | (7,608) | (4,292) | ||
| Net loss available to common stockholders, diluted: | (7,608) | (4,292) | ||
Comprehensive Income ($ in thousands)
| 3/31/2015 TTM | 6/30/2014 | 6/30/2013 | ||
|---|---|---|---|---|
| Net loss: | (7,608) | (4,292) | ||
| Comprehensive loss, net of tax, attributable to parent: | (7,608) | (4,292) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.